MRC study: When to commence treatment in advanced prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 1, Issue 1, 1997, Pages 11-15

  Kirk, D ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Advanced prostate cancer; Hormone treatment immediate versus deferred treatment

Indexed keywords

EID: 0002992869     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500207     Document Type: Article

References (13)

1. Editorial. Dilemmas in the management of prostatic cancer. Lancet 1985; ii: 1219-1220.
2. Nesbit RM, Baum WC. Endocrine control of prostatic cancer. Clinical survey of 1818 cases. JAMA 1950; 143: 1317-1320.
3. Byar DP. The Veterans Administration Cooperative Research Group's studies of cancer of the prostate. Cancer 1973; 32: 1126-1130.
4. Kirk D. Trials and tribulations in prostatic cancer. Br J Urol 1987; 59: 375-379.
5. Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol 1997; 79: 235-246.
6. Jacobi GH. Hormonal treatment of metastatic carcinoma of the prostate. In: Fitzpatrick JM, Krane RJ (eds). The Prostate. Churchill Livingstone: Edinburgh, 1989, pp 389-399.
7. Kirk D. Deferred treatment for advanced prostatic cancer. In: Waxman J, Williams G (eds). Urological Oncology. Edward Arnold: Sevenoaks, 1991, pp 117-125.
8. Kozlowski JM, Ellis WJ, Grayhack JT. Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin N Amer 1991; 15: 15-24.
9. Crawford ED et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Eng J Med 1989; 321: 419-124.
10. Armitage TG et al. The value of measurements of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Br J Urol 1988; 62: 584-589.
11. Kirk D and the MRC Prostate Cancer Working Party and Investigators Group. Complications in advanced prostate cancer: data from the Medical Research Council immediate versus deferred treatment study (abstract). Br J Urol 79: suppl 4: 27.
12. Josefsen D, Waehre H, Paus E, Fossa SD. Increase in serum prostate specific antigen and clinical progression in pN+ M0 prostate cancer. Br J Urol 1995; 75: 502-506.
13. Fellows GJ et al. Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Br J Urol 1992; 70: 304-309.